This prospective cohort study investigated the relationship between the combined atherogenic-frailty index (AIP-FI) and the development of cardiometabolic multimorbidity (CMM). The research included 4,157 participants aged 45 years and older without existing CMM from CHARLS.
Key Clinical Findings
Over an 8.5-year follow-up, 612 incident CMM cases were observed. Higher baseline and cumulative AIP-FI levels were significantly associated with increased CMM risk. Cumulative exposure demonstrated a stronger effect on risk, with a hazard ratio of 1.46 per standard deviation increment (95% CI: 1.38-1.54). Individuals in the highest quartile of cumulative AIP-FI exhibited a near four-fold higher CMM risk compared to those in the lowest quartile (HR = 3.95; 95% CI = 2.95-5.29). Clustering analyses indicated that groups with high-stable AIP-FI displayed the highest CMM risks. The use of cumulative AIP-FI improved predictive performance for CMM (AUC = 71.17%) and significantly enhanced risk reclassification compared to traditional markers.
Study Implications
Mediation analyses suggested bidirectional synergistic effects between AIP and FI. This study highlights the importance of monitoring the cumulative burden and dynamic trajectories of